A delegation of 5 leading UK HealthTech innovator companies has just returned from Minnesota, USA as part of a highly successful US Market Access Programme between Medilink, the leading life sciences organisation in the UK and the world-famous Medical Alley in Minnesota USA.
From left to right: Peder Hatling, Danny Forde, Matthew Bacon, Jeff McBride, Rashmi Raju, Nicky Johnson, Ellie Cannon, Filip Kostal.
The programme delivered invaluable market information, regulatory guidance, market access modelling and first-hand experience for each of the UK companies over a three-week period.
The first week included online digital sessions on Go-to-Market strategy, Regulatory consideration, Security requirements in Healthcare, Venture Capital and Raising Money in the US and Sales and Marketing. Week two included a market visit to Minneapolis in Minnesota for in-depth discussion and learning on Health System and Payers in the US market and Corporate Development and Partnerships and included Investors, Entrepreneur roundtables and Reimbursement workshop. Week three provided a platform for each of the innovator companies to present an online showcase pitch to connect with potential contacts, key partners and valuable resources.
Danny Forde, Director of Business Development and External Relations from Class Medical Ltd, said, “The virtual sessions provided invaluable insights, and we’re eager to build on this by engaging directly with key stakeholders in the US – a crucial market for the TUCSV. Thank you Medilink for a great programme and a very productive and enjoyable week in Minneapolis. Lots of great connections made and I’m looking forward to the showcase in the coming weeks.”
Jeff McBride, Founder and Chairman of Panacea, said, “I was thrilled to participate in the Medilink UK Market Access Programme in Minnesota. It was a fantastic opportunity to connect with key stakeholders and gain valuable insights into the US market.”
Rashmi Raju, International Manager at Medilink added, “It was exciting to be in Minnesota as part of our in-market session for the Medilink Market Access Programme in partnership with Medical Alley. It was also encouraging to see our delegates engaging with industry leaders, gaining insights into the U.S. MedTech landscape, and exploring opportunities in this innovative and dynamic ecosystem. Exciting opportunities ahead for our UK companies!”
Peder Hatling, Director at Medical Alley added, “We were thrilled to host such an impressive cohort from Medilink. These elite startups joined us in beautiful Minneapolis, Minnesota USA to get a firsthand look at succeeding in the US market. The speakers we lined up to meet this cohort were some of the most accomplished healthcare practitioners, entrepreneurs, and investors in the market. Moreover, they represented a broad variety of healthcare companies and providers, from the very largest multinationals to localized players. We all look forward to continuing to work with these promising UK startups.”
Medical Alley
As well as representing a network of more than eight hundred healthcare industry organisations working together to change healthcare for the better, Medical Alley is a think tank, business accelerator, legislative advocate, recruiting resource and source of news/insights all in one.
Medilink International Market Access
Medilink’s International trade and sector specialists work with UK healthcare businesses to identify opportunities in new international markets, creating bespoke entry strategies for companies of all sizes. To learn more visit International Market Access.
Medilink North of England is a professional membership association and specialist consultancy for the life sciences sector, part of Medilink UK, they help businesses and organisations to innovate and prosper by improving sector connectivity and identifying opportunities, as well as helping organisations to grow by providing cost-effective consultancy support to become more competitive and profitable.
Left to right: Danny Forde, Jeff McBride, Rashmi Raju, Nicky Johnson, Matthew Bacon, Joseph Bentley.